ÌÇÐÄÆƽâ°æ

Revenue of GSK Pharmaceuticals India from drug sales as of February 2022, by leading drug (in million Indian rupees)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2022

Region

India

Survey time period

February 2022

Supplementary notes

One Indian rupee is equal to 0.012 U.S. dollars and 0.011 euros (as of May 2023).
Values have been rounded for clarity.

Citation formats

GSK Pharmaceuticals India's sales 2022, by leading drug

Published by A. Minhas, May 17, 2023
As of February 2022, the pharmaceutical company, GSK, in India saw the highest revenue from its anti-infective Augmentin drug sales, amounting to above * Indian rupees. Comparatively, Infanrix Hexa generated a revenue of over *** billion Indian rupees. GlaxoSmithKline Pharmaceuticals India produces drugs for various therapies such as derma, hormones, vaccines, and analgesics.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India

Market overview

6

GSK India - key figures

6

Main competitiors

4

Product portfolio

3

Further Content: You might find this interesting as well

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.